e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Treatment Resistant Depression
Recent news which mentions Treatment Resistant Depression
Building Australia's Psychedelics Industry: A New Joint Venture And Why It's Important
May 26, 2023
Tags
GMP Certification
Benzinga
PTSD treatment
From
Benzinga
atai Life Sciences' Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges
January 06, 2023
Tickers
ATAI
Tags
Perception Neuroscience
Benzinga
Small Cap
From
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
ENVB
Drug Enforcement Administration
MNMD
From
Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
December 22, 2022
Tags
Beckley Psytech
Psychedelics
Markets
From
Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
November 04, 2022
Tickers
BMNDF
Tags
Drug Delivery Technologies
Benzinga
BMNDF
From
Benzinga
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
October 26, 2022
Tickers
ATAI
Tags
Ketamine
Penny Stocks
Psychedelics
From
Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
August 23, 2022
Tickers
GHRS
Tags
Treatment Resistant Depression
GH001
Small Cap
From
Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
August 15, 2022
Tickers
ATAI
HTGC
Tags
Mid Cap
Michael Dutra
Psychedelics
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.